Piper Sandler Raises Oracle Price Target to $225
Piper Sandler analyst Billy Fitzsimmons raised the price target on Oracle (NYSE: ORCL) to $225.00 (from $210.00) while maintaining an Overweight rating.
“ORCL capped off its fiscal year by reporting a slight rev beat and an RPO balance of $638B (+363% y/y), up a sizable $85.4B q/q. FY27 rev guidance was left unchanged at $90B.
However, mgmt guided capex to $90B-$95B (consensus: $61.2B), though the net cash outlay will be smaller given an expected $20-$25B of customer prepayments.
ORCL will raise an additional $40B in FY27 between debt/equity to bridge the gap (inclusive of $20B remaining on existing equity issuance plan).
We believe ORCL will remain debated, but we are constructive on ORCL’s AI-driven consumption growth, believe the FY27 rev guide is reasonable, and walked away from the callback with increased confidence in mgmt’s ability to protect OCI mgns against rising component costs.
Raising PT to $225. Maintain OW.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
